Cellectar Biosciences, Inc. (CLRB) stock
CLRBNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.92−0.09 (-8.88%)
Close on Nov 17, 2026Market cap $8.70MP/E –Yield –
Cellectar Biosciences pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Cellectar Biosciences's pe ratio was 1.5× on Jan 31, 2017.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2017 | Jan 31, 2017 | 1.5× | +0.4 |
| 2016 | Dec 30, 2016 | 1.1× | – |
See a number that looks wrong?